# Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer

> **NCT03485027** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 43 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Chemotherapy Effect

## Interventions

- **DRUG:** the rechallenge regimen

## Key facts

- **NCT ID:** NCT03485027
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2022-12-24
- **Final completion:** 2023-07-01
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03485027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03485027, "Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03485027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*